Biomarker Discovery Services
Biomarkers discovered, identified, and validated early in drug research can be used throughout the drug development
process to:
- Select for benefit or avoid harm of a drug prior to
entering the clinic or during clinical study
- Select an optimal initial and/or maintenance dose
of drug
- Inform subsequent clinical trial design to stratifypatient populations for clinical study
Genpathway develops disease-related biomarkers using
ChIP-based sequencing technologies. Our approach to
biomarker discovery differs from the current generation of
molecular-based RNA/gene expression approaches in that
we measure DNA-protein interactions or gene-regulated events
within the cell nucleus to elucidate the causal pathways of
disease and/or the predictive pharmacological action of
potential drugs.
© 2010 Genpathway, Inc.